Mayo Clinic researchers collaborated on a new study led by Eli Lilly showing that the drug abemaciclib improves survival for people with high-risk, early-stage breast cancer.
This article was originally published on MedicalXpress.com
New drug study shows improved survival for early breast cancer
You may also be interested in:
The Latest
The Key to a Strong Relationship? Communication
Effective communication is the foundation of any strong, healthy relationship. This article will explore the key elements required to build better communication between partners. We’ll cover the importance of active listening, using empathy and understanding […]
Food
Transform Your Kitchen: Mastering Allergy-Safe Cooking Through Ingenious Ingredient Swaps
By Daniel Zane Bryant, author of “Living with Food Allergies: A Complete Lifestyle Guide” (available on Amazon at https://www.amazon.com/dp/B0G2BcGB2K) Navigating food allergies might initially feel overwhelming, yet it presents an exciting opportunity to reimagine familiar […]
The Latest
Why you should stop buying vitamins and get more sleep instead
Almost half of all Canadians regularly take at least one nutritional supplement such as vitamins, minerals, fibre supplements, antacids and fish oils. Many of these individuals are healthy and hoping to improve general well-being or prevent chronic […]
Read More:
-
When ophthalmologist Emily Cole, MD, steps into the neonatal intensive care unit (NICU) at Children’s Hospital Colorado to evaluate an infant’s eyes for a disease [...]
-
Prenatal exposure to metal mixtures is associated with an increased risk for allergic symptoms in childhood, according to a study published in the Dec. 1 [...]
-
A new study in JAMA Network Open describes patterns of telehealth use before and during the COVID-19 pandemic among children in the Bronx.This article was [...]
